ストックスクリーナーアプリを入手
4.22
0.94%
-0.04
前日終値:
$4.26
開ける：
$4.29
24時間の取引高:
275.58K
Relative Volume:
0.66
時価総額：
$230.52M
収益：
$163.78M
当期純損益:
$25.88M
株価収益率:
6.4923
EPS:
0.65
ネットキャッシュフロー:
$-28.66M
1週間 パフォーマンス:
-0.24%
1か月 パフォーマンス:
-19.16%
6か月 パフォーマンス:
-38.57%
1年 パフォーマンス:
-44.76%
1日の値動き範囲:
$4.205
$4.3537
1週間の範囲:
$4.205
$4.53
52週間の値動き範囲:
$4.0013
$10.66
Voyager Therapeutics Inc Stock (VYGR) Company Profile
名前
Voyager Therapeutics Inc
セクター
電話
857-259-5340
住所
75 HAYDEN AVENUE, LEXINGTON, MA
VYGR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.22 | 230.52M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 開始されました | Citigroup | Buy |
| 2024-11-29 | 再開されました | Wedbush | Outperform |
| 2024-10-16 | 開始されました | Leerink Partners | Outperform |
| 2024-03-26 | 開始されました | Guggenheim | Buy |
| 2024-03-19 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-07 | 開始されました | Citigroup | Buy |
| 2024-01-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 開始されました | Truist | Buy |
| 2023-03-10 | 開始されました | Oppenheimer | Outperform |
| 2021-10-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-02-03 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-12-24 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-11-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 開始されました | The Benchmark Company | Buy |
| 2020-02-06 | 開始されました | Oppenheimer | Outperform |
| 2018-11-15 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-09-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-02-02 | 開始されました | Morgan Stanley | Overweight |
| 2017-11-28 | 再開されました | Piper Jaffray | Overweight |
| 2017-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2017-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2017-10-23 | 繰り返されました | Stifel | Buy |
| 2017-10-12 | 開始されました | Raymond James | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-28 | 再開されました | Stifel | Buy |
すべてを表示
Voyager Therapeutics Inc (VYGR) 最新ニュース
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
Levi & Korsinsky Reminds Voyager Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsVYGR - ACCESS Newswire
Lost Money on Voyager Therapeutics, Inc. (VYGR)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Wednesday - MarketBeat
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire Inc.
Voyager Therapeutics stock hits 52-week low at $4.12 By Investing.com - Investing.com Nigeria
Voyager Therapeutics reassesses SOD1-ALS gene therapy program - ALS News Today
Wedbush Has Bearish Estimate for VYGR FY2025 Earnings - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc.VYGR - PR Newswire
Research Analysts Set Expectations for VYGR FY2029 Earnings - MarketBeat
Wedbush Predicts Lower Earnings for Voyager Therapeutics - Armenian Reporter
Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock - MSN
Voyager Therapeutics (NASDAQ:VYGR) Receives "Outperform" Rating from Wedbush - MarketBeat
Equities Analysts Issue Forecasts for VYGR FY2025 Earnings - Defense World
Voyager Therapeutics COO Robin Swartz sells $30,927 in stock - MSN
Brokers Issue Forecasts for VYGR FY2029 Earnings - Defense World
A company insider recently sold 5,413 shares of Voyager Therapeutics Inc [VYGR]. Should You Sale? - Knox Daily
Voyager Therapeutics COO Robin Swartz sells $30,927 in stock By Investing.com - Investing.com Australia
Voyager Therapeutics' chief legal officer sells $19,393 in stock - MSN
Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock By Investing.com - Investing.com Australia
Voyager Therapeutics’ chief legal officer sells $19,393 in stock By Investing.com - Investing.com Nigeria
Voyager Therapeutics stock hits 52-week low at $4.12 - MSN
Voyager Therapeutics' chief scientific officer sells shares worth $24,087 - MSN
Voyager Therapeutics’ chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com Nigeria
Voyager Therapeutics' chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com South Africa
Voyager Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
Voyager Therapeutics' chief legal officer sells $19,393 in stock By Investing.com - Investing.com UK
Voyager Therapeutics Executives Sell Shares - TradingView
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Insider Monkey
Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher - Simply Wall St
Voyager updates on SOD1 ALS gene therapy program - The Pharma Letter
Voyager Therapeutics (NASDAQ:VYGR) Given “Outperform” Rating at Wedbush - Defense World
SG Americas Securities LLC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
10 Cheap Biotech Stocks to Invest in Now - Insider Monkey
Voyager Therapeutics shifts focus for ALS therapy - MSN
Voyager Therapeutics stock tumbles after IND application delayed - MSN
Voyager Therapeutics stock tumbles after IND application delayed By Investing.com - Investing.com Canada
Voyager Therapeutics shifts focus for ALS therapy By Investing.com - Investing.com Australia
Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating - Marketscreener.com
Voyager Provides Update on SOD1 ALS Gene Therapy Program - GlobeNewswire
Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload - Fierce Biotech
Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025 - Marketscreener.com
Voyager Therapeutics Inc (VYGR) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):